rs71561434
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015571.4(SENP6):c.-523C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0953 in 153,900 control chromosomes in the GnomAD database, including 739 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.095   (  728   hom.,  cov: 33) 
 Exomes 𝑓:  0.087   (  11   hom.  ) 
Consequence
 SENP6
NM_015571.4 5_prime_UTR
NM_015571.4 5_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.804  
Publications
7 publications found 
Genes affected
 SENP6  (HGNC:20944):  (SUMO specific peptidase 6) Ubiquitin-like molecules (UBLs), such as SUMO1 (UBL1; MIM 601912), are structurally related to ubiquitin (MIM 191339) and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 (MIM 602362) to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA; MIM 164008) from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins (Kim et al., 2000 [PubMed 10799485]). SENPs also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SENP6 | NM_015571.4 | c.-523C>T | 5_prime_UTR_variant | Exon 1 of 24 | ENST00000447266.7 | NP_056386.2 | ||
| SENP6 | NM_001100409.3 | c.-523C>T | 5_prime_UTR_variant | Exon 1 of 23 | NP_001093879.1 | |||
| SENP6 | NM_001304792.2 | c.-523C>T | 5_prime_UTR_variant | Exon 1 of 15 | NP_001291721.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0955  AC: 14508AN: 151980Hom.:  727  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
14508
AN: 
151980
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0875  AC: 158AN: 1806Hom.:  11  Cov.: 0 AF XY:  0.0968  AC XY: 110AN XY: 1136 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
158
AN: 
1806
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
110
AN XY: 
1136
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
30
American (AMR) 
 AF: 
AC: 
2
AN: 
24
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
28
East Asian (EAS) 
 AF: 
AC: 
4
AN: 
46
South Asian (SAS) 
 AF: 
AC: 
22
AN: 
212
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
62
Middle Eastern (MID) 
AC: 
0
AN: 
0
European-Non Finnish (NFE) 
 AF: 
AC: 
122
AN: 
1312
Other (OTH) 
 AF: 
AC: 
6
AN: 
92
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 6 
 13 
 19 
 26 
 32 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0954  AC: 14516AN: 152094Hom.:  728  Cov.: 33 AF XY:  0.0958  AC XY: 7121AN XY: 74342 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
14516
AN: 
152094
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
7121
AN XY: 
74342
show subpopulations 
African (AFR) 
 AF: 
AC: 
3272
AN: 
41532
American (AMR) 
 AF: 
AC: 
1368
AN: 
15296
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
326
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
201
AN: 
5156
South Asian (SAS) 
 AF: 
AC: 
494
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
1344
AN: 
10554
Middle Eastern (MID) 
 AF: 
AC: 
28
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
7183
AN: 
67944
Other (OTH) 
 AF: 
AC: 
211
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.490 
Heterozygous variant carriers
 0 
 668 
 1337 
 2005 
 2674 
 3342 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 158 
 316 
 474 
 632 
 790 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
243
AN: 
3472
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.